Skip to main content
Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Odyssey Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 TTM Dec '23 Dec '22
Cash & Equivalents
39.4452.55241.04
Short-Term Investments
115.47134.45-
Cash & Cash Equivalents
154.9187241.04
Cash Growth
--22.42%-
Other Current Assets
4.935.547.67
Total Current Assets
159.83192.54248.71
Property, Plant & Equipment
-15.9817.88
Long-Term Investments
-29.1-
Goodwill and Intangibles
-45.2248.96
Other Long-Term Assets
-3.691.61
Total Long-Term Assets
-93.9968.44
Total Assets
-286.52317.15
Accounts Payable
-7.738.05
Current Debt
-22.0922.8
Other Current Liabilities
25.11-7.73-8.05
Total Current Liabilities
25.1122.0922.8
Long-Term Debt
-30.5239.14
Other Long-Term Liabilities
-8.418.2
Total Long-Term Liabilities
-38.9447.34
Total Liabilities
-61.0270.14
Total Debt
32.0952.6161.93
Debt Growth
--15.05%-
Retained Earnings
--289.09-158.17
Comprehensive Income
--0.86-2.18
Shareholders' Equity
-349.27-262.71-144.62
Net Cash / Debt
122.81134.39179.11
Net Cash / Debt Growth
--24.97%-
Working Capital
134.73170.45225.92
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).